Tag - BBI

Developments

Brickell Biotech changes name to Fresh Tracks Therapeutics

Brickell Biotech (NASDAQ:BBI) changed its name to Fresh Tracks Therapeutics, with a new stock symbol, FRTX, effective at the NASDAQ opening on Sept. 8, 2022. The unveiling of the company’s rebranding reinforces...

September 7, 2022

Feature

Brickell Biotech pivots to make fresh tracks in autoimmune, inflammatory medicine

After selling its late-stage dermatology program in May 2022, Brickell Biotech (NASDAQ:BBI) has pivoted its focus to developing differentiated therapeutics for the treatment of autoimmune, inflammatory and other...

August 9, 2022

Markets

WB starts Brickell Biotech at OP; fair value estimate $2

William Blair initiated coverage of Brickell Biotech (NASDAQ:BBI) with an “outperform” rating and fair value estimate of $2. The stock closed at 21 cents on March 7. Brickell is a biopharmaceutical company focused on...

March 8, 2022

Tag - BBI

Brickell Biotech changes name to Fresh Tracks Therapeutics

Brickell Biotech pivots to make fresh tracks in autoimmune, inflammatory medicine

WB starts Brickell Biotech at OP; fair value estimate $2

General

More